Literature DB >> 3030922

Malignant rhabdoid tumor of the central nervous system.

P J Biggs, P D Garen, J M Powers, A J Garvin.   

Abstract

Originally described and most frequently reported in association with the kidney, the malignant rhabdoid tumor (MRT) is a highly aggressive neoplasm with distinctive morphologic features. Extrarenal sites reported for this neoplasm include the liver, thymus, and various soft tissue sites. Young infants are affected with rare exceptions. We report the case of a 3-month-old boy who presented with hyperirritability and increasing head size over several weeks. The patient died following a two-week hospital stay marked by development of seizures, paralysis, and apnea. At autopsy, significant findings were limited to the central nervous system. The subarachnoid space contained neoplasm throughout, with multiple areas of parenchymal invasion. A predominating intraparenchymal mass was present in the inferior cerebellum contiguous with the neoplasm in the subarachnoid space and probably represented the site of origin. Microscopically, the neoplasm was composed of a highly cellular monomorphic population of polygonal cells with roughly ovoid vesicular nuclei and conspicuous nucleoli. Variable amounts of cytoplasm were present, and many cells contained a single, well-demarcated eosinophilic hyaline globule adjacent to the nucleus. Ultrastructurally, the cytoplasmic globules were composed of whorled aggregates of intermediate filaments. Immunoperoxidase studies confirmed that the filaments were composed, at least in part, of vimentin. The morphologic and immunohistochemical features are diagnostic of MRT, an entity of unknown histogenesis that has not been reported previously as a primary neoplasm of the CNS.

Entities:  

Mesh:

Year:  1987        PMID: 3030922     DOI: 10.1016/s0046-8177(87)80161-2

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  45 in total

1.  Study of the gene expression and microRNA expression profiles of malignant rhabdoid tumors originated in the brain (AT/RT) and in the kidney (RTK).

Authors:  Alex T Grupenmacher; Abby L Halpern; Maria de Fátima Bonaldo; Chiang-Ching Huang; Christopher A Hamm; Alexandre de Andrade; Tadanori Tomita; Simone T Sredni
Journal:  Childs Nerv Syst       Date:  2013-09-03       Impact factor: 1.475

2.  Cerebral rhabdomyosarcoma with rhabdoid tumor-like features.

Authors:  V Caputo; M L Repetti; N Grimoldi; G Lazzarini; B Masini; F Radice
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

3.  Malignant rhabdoid tumor: primary intracranial manifestation in an adult.

Authors:  M Horn; W Schlote; K D Lerch; W I Steudel; D Harms; E Thomas
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

4.  Imaging findings in primary intracranial atypical teratoid/rhabdoid tumors.

Authors:  Hemant Parmar; Cynthia Hawkins; Eric Bouffet; James Rutka; Manohar Shroff
Journal:  Pediatr Radiol       Date:  2005-12-08

5.  Rhabdoid tumours of the central nervous system. Report of three cases with immunocytochemical and ultrastructural findings.

Authors:  A Cossu; G Massarelli; V Manetto; G Viale; F Tanda; L Bosincu; P Iuzzolino; S Cossu; R Padovani; V Eusebi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

6.  MRI of congenital rhabdoid tumor of the neck: case report.

Authors:  S S Roy; S K Mukherji; M Castillo; T O'Connell
Journal:  Neuroradiology       Date:  1996-05       Impact factor: 2.804

7.  The existence of rhabdoid cells in specified soft tissue sarcomas. Histopathological, ultrastructural and immunohistochemical evidence.

Authors:  M Tsuneyoshi; Y Daimaru; H Hashimoto; M Enjoji
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

8.  Central nervous system atypical teratoid rhabdoid tumor: experience at the National Institute of Pediatrics, Mexico City.

Authors:  Beatriz de León-Bojorge; Fernando Rueda-Franco; Marcial Anaya-Jara
Journal:  Childs Nerv Syst       Date:  2007-09-18       Impact factor: 1.475

9.  Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumors.

Authors:  Yushui Wu; Xueqing Lun; Hongyuan Zhou; Limei Wang; Beichen Sun; John C Bell; John W Barrett; Grant McFadden; Jaclyn A Biegel; Donna L Senger; Peter A Forsyth
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

10.  Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas.

Authors:  Naohiko Ikegaki; Hiroyuki Shimada; Autumn M Fox; Paul L Regan; Joshua R Jacobs; Sakeenah L Hicks; Eric F Rappaport; Xao X Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.